Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

Eugene Shenderov; Michael A. Gorin; Seohyun Kim; Pamela T. Johnson; Mohamad E. Allaf; Alan W. Partin; Martin G. Pomper; Emmanuel S. Antonarakis; Kenneth J. Pienta; Steven P. Rowe

doi:10.1016/j.eucr.2017.12.011

Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [¹⁸F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation

Eugene Shenderov
, Michael A. Gorin
, Seohyun Kim
, Pamela T. Johnson
, Mohamad E. Allaf
, Alan W. Partin
, Martin G. Pomper
, Emmanuel S. Antonarakis
, Kenneth J. Pienta
, Steven P. Rowe

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

Radiotracers targeting prostate-specific membrane antigen (PSMA), including [¹⁸F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [¹⁸F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

Original language	English (US)
Pages (from-to)	22-25
Number of pages	4
Journal	Urology Case Reports
Volume	17
DOIs	https://doi.org/10.1016/j.eucr.2017.12.011
State	Published - Mar 2018
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Carcinoid
PSMA
Prostate cancer

Publisher link

10.1016/j.eucr.2017.12.011

Find It

Find It at U of M Libraries

Cite this

Shenderov, E., Gorin, M. A., Kim, S., Johnson, P. T., Allaf, M. E., Partin, A. W., Pomper, M. G., Antonarakis, E. S., Pienta, K. J., & Rowe, S. P. (2018). Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [¹⁸F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation. Urology Case Reports, 17, 22-25. https://doi.org/10.1016/j.eucr.2017.12.011

Shenderov, E, Gorin, MA, Kim, S, Johnson, PT, Allaf, ME, Partin, AW, Pomper, MG, Antonarakis, ES, Pienta, KJ & Rowe, SP 2018, 'Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [¹⁸F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation', Urology Case Reports, vol. 17, pp. 22-25. https://doi.org/10.1016/j.eucr.2017.12.011

@article{5a7964763c9b4aa18290eebbc296bb36,

title = "Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT: Value of the PSMA-RADS-3D Designation",

abstract = "Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).",

keywords = "Carcinoid, PSMA, Prostate cancer",

author = "Eugene Shenderov and Gorin, \{Michael A.\} and Seohyun Kim and Johnson, \{Pamela T.\} and Allaf, \{Mohamad E.\} and Partin, \{Alan W.\} and Pomper, \{Martin G.\} and Antonarakis, \{Emmanuel S.\} and Pienta, \{Kenneth J.\} and Rowe, \{Steven P.\}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2018",

month = mar,

doi = "10.1016/j.eucr.2017.12.011",

language = "English (US)",

volume = "17",

pages = "22--25",

journal = "Urology Case Reports",

issn = "2214-4420",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Diagnosing small bowel carcinoid tumor in a patient with oligometastatic prostate cancer imaged with PSMA-Targeted [18F]DCFPyL PET/CT

T2 - Value of the PSMA-RADS-3D Designation

AU - Shenderov, Eugene

AU - Gorin, Michael A.

AU - Kim, Seohyun

AU - Johnson, Pamela T.

AU - Allaf, Mohamad E.

AU - Partin, Alan W.

AU - Pomper, Martin G.

AU - Antonarakis, Emmanuel S.

AU - Pienta, Kenneth J.

AU - Rowe, Steven P.

PY - 2018/3

Y1 - 2018/3

N2 - Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

AB - Radiotracers targeting prostate-specific membrane antigen (PSMA), including [18F]DCFPyL, have been extensively investigated as a means to image prostate cancer more accurately. We present the case of a man with oligometastatic prostate cancer who was also diagnosed with a metastatic small bowel carcinoid tumor following the detection of indeterminate findings on a [18F]DCFPyL PET and discuss how this case highlights the utility of a newly proposed reporting system for PSMA-targeted PET (PSMA-RADS version 1.0).

KW - Carcinoid

KW - PSMA

KW - Prostate cancer

UR - https://www.scopus.com/pages/publications/85038890850

UR - https://www.scopus.com/pages/publications/85038890850#tab=citedBy

U2 - 10.1016/j.eucr.2017.12.011

DO - 10.1016/j.eucr.2017.12.011

M3 - Article

AN - SCOPUS:85038890850

SN - 2214-4420

VL - 17

SP - 22

EP - 25

JO - Urology Case Reports

JF - Urology Case Reports

ER -